Diabetes medications and cardiovascular outcome trials: Lessons learned

被引：11
|
作者：
Patel, Kershaw V. [1 ]
Rocha, Natalia de Albuquerque [1 ]
McGuire, Darren K. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2017年 / 84卷 / 10期
关键词：
HEART-FAILURE; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; TYPE-2; SITAGLIPTIN; MELLITUS; INHIBITION; EXENATIDE; IMPROVES; COTRANSPORTERS;
D O I：
10.3949/ccjm.84gr.17006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The US Food and Drug Administration's current standards require that new diabetes medications demonstrate cardiovascular safety in large, long-term trials. New drugs that have been assessed in such trials are changing the management of type 2 diabetes.
引用
收藏
页码：759 / 767
页数：9
相关论文
共 50 条
  • [31] EMPA-REG OUTCOME: cardiovascular outcome trials in diabetes come of age
    Krentz, Andrew J.
    CARDIOVASCULAR ENDOCRINOLOGY, 2015, 4 (04): : 115 - 116
  • [32] Series: Cardiovascular outcome trials for diabetes drugs Degludec and DEVOTE
    Fisher, Miles
    BRITISH JOURNAL OF DIABETES, 2021, 21 (01): : 113 - 115
  • [33] Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes
    Hoppe, Charis
    Kerr, David
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (01): : 13 - 13
  • [34] PDM-ProValue meets cardiovascular outcome trials in diabetes
    Katharina Fritzen
    Oliver Schnell
    Cardiovascular Diabetology, 18
  • [35] Series: Cardiovascular outcome trials for diabetes drugs Lixisenatide and ELIXA
    Fisher, Miles
    BRITISH JOURNAL OF DIABETES, 2020, 20 (01): : 52 - 54
  • [36] Series: Cardiovascular outcome trials for diabetes drugs Liraglutide and LEADER
    Fisher, Miles
    BRITISH JOURNAL OF DIABETES, 2020, 20 (02): : 142 - 144
  • [37] PDM-ProValue meets cardiovascular outcome trials in diabetes
    Fritzen, Katharina
    Schnell, Oliver
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [38] Cardiovascular outcome trials in type 2 diabetes: A critical analysis
    Ashraf, Hamid
    Ahmad, Jamal
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 300 - 305
  • [39] Series: Cardiovascular outcome trials for diabetes drugs Sitagliptin and TECOS
    Fisher, Miles
    BRITISH JOURNAL OF DIABETES, 2020, 20 (01): : 55 - 57
  • [40] Cardiovascular outcome trials in diabetes: what have we learnt?
    Kirby, Mike
    Boon, Nick
    TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 7 - 12
12345